The hidden crisis in early-phase cancer trials: A challenge to be bold, creative and fearless

Why the UK Is Now a Strategic Hub for Early Clinical Trials.

As we manage the conduct of your complex study, we never take our eyes off the two critical focal points—scientific integrity and human subject safety.

Strengthening our commitment to sustainability at the Leeds Drapers Yard Clinical Research Unit (CRU)

MHRA’s regulatory renaissance: Why the UK is now a strategic hub for early clinical trials

Why has the UK emerged as a strategic hub for early-phase clinical trials?

Fortrea Thought Leadership: Unraveling the Link Between Obesity, Metabolic Inflammation, and Cancer

Fortrea’s latest review uncovers the molecular links between metabolic inflammation, obesity and cancer—and highlights new opportunities for prevention and precision oncology.

Hope in a Dose: A Cell and Gene Therapy (CGT) Podcast

Safety Blog: AI in Medical Writing: Disruption or Evolution?

Leeds

Discover Fortrea’s Leeds Clinical Research Unit — delivering early-phase clinical trial excellence with advanced facilities, expert teams, and UK’s strong research ecosystem.

Reducing white space in early-stage drug development: Strategies for streamlined success

Enabling success in global clinical trials: Fortrea’s strategic solutions for biotech